Spain · AEMPS CIMA

EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO SANDOZ 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
82517
Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Composition / generic term
efavirenz + emtricitabina + tenofovir
Source strength
600 - REVISAR mg
Authorisation holder
Sandoz Farmaceutica S.A.
Marketed in source snapshot
No

Source-listed ingredients

  • EFAVIRENZ — 600 mg
  • EMTRICITABINA — 200 mg
  • TENOFOVIR DISOPROXILO SUCCINATO — 300,6 mg

These values do not establish equivalence or a dose recommendation.

Packages

  • EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO SANDOZ 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos
  • EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO SANDOZ 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG,30 comprimidos

Source and coverage

Open AEMPS CIMA →

Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Spain records →